Sun Heng, Wang Jianhua
Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, 400044, China.
Analyst. 2023 Jan 31;148(3):454-474. doi: 10.1039/d2an01591a.
Proteins are major drug targets, and drug-target interaction identification and analysis are important factors for drug discovery. Atomic force microscopy (AFM) is a powerful tool making it possible to image proteins with nanometric resolution and probe intermolecular forces under physiological conditions. We review recent studies conducted in the field of target protein drug discovery using AFM-based analysis technology, including drug-driven changes in nanomechanical properties of protein morphology and interactions. Underlying mechanisms (including thermodynamic and kinetic parameters) of the drug-target interaction and drug-modulating protein-protein interaction (PPI) on the surfaces of models or living cells are discussed. Furthermore, challenges and the outlook for the field are likewise discussed. Overall, this insight into the mechanical properties of protein-drug interactions provides an unprecedented information framework for rational drug discovery in the pharmaceutical field.
蛋白质是主要的药物靶点,药物-靶点相互作用的识别与分析是药物研发的重要因素。原子力显微镜(AFM)是一种强大的工具,它能够在生理条件下以纳米分辨率对蛋白质进行成像并探测分子间力。我们综述了利用基于AFM的分析技术在靶蛋白药物研发领域开展的最新研究,包括药物驱动的蛋白质形态纳米力学性质变化及相互作用。讨论了药物-靶点相互作用以及药物在模型或活细胞表面调节蛋白质-蛋白质相互作用(PPI)的潜在机制(包括热力学和动力学参数)。此外,还讨论了该领域面临的挑战和前景。总体而言,这种对蛋白质-药物相互作用力学性质的深入了解为制药领域合理的药物研发提供了前所未有的信息框架。